Abstract: A system for construction project resource management including a plurality of interactive modules that track construction resources and determine construction compliance with construction plans. One of the plurality of interactive modules is a tracking module configured to physically track assets, materials, equipment and labour. One of said plurality of interactive modules is a compliance module configured to comparing actual construction data with project plan specifications. The compliance module may be further configured to receive actual construction data from the tracking module and may be further configured to transmit the compared data to a user. Another one of said plurality of interactive modules is a smart contract module configured to receive an order request, process the received order request into a project bid, and process the project bid to secure a success bid for the received order request.

Abstract: The present invention relates to carboxamide halogenated porphyrin derivatives, in particular bacteriochlorin or chlorin, of formula (I) use of the same or a pharmaceutically acceptable salt thereof in photodynamic therapy, where the derivatives are able to detect and exhibit the presence of hyperproliferative disorders and, in the presence of an adequate lighting, to treat the same. The present invention also describes a pharmaceutical composition having the carboxamide halogenated porphyrin derivatives, in particular bacteria-chlorin or chlorin, of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of cancer and/or microbial and/or viral infections, in humans or animals.

Abstract: The present invention relates to carboxamide halogenated porphyrin derivatives, in particular bacteriochlorin or chlorin, of formula (I) use of the same or a pharmaceutically acceptable salt thereof in photodynamic therapy, where the derivatives are able to detect and exhibit the presence of hyperproliferative disorders and, in the presence of an adequate lighting, to treat the same. The present invention also describes a pharmaceutical composition having the carboxamide halogenated porphyrin derivatives, in particular bacteria-chlorin or chlorin, of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of cancer and/or microbial and/or viral infections, in humans or animals.